Skip to content
Search

Latest Stories

Pharmacy Business Diversity Conference - session summary: 'Open conversation is key to resolving race and ethnicity challenge'

The issues related to race and ethnicity are common across the sectors, but the problem is not unsolvable, said panelists in a discussion on Race, Identity and Belonging In The Workplace, held during the Pharmacy Business Diversity Conference on Thursday (December 9).

Creating safe and comfortable spaces and allowing authentic conversations is a precursor to resolving this big challenge, said Zaheer Ahmad MBE, global head of Inclusion and Diversity at GSK Consumer Healthcare.


The session, moderated by the conference chair BBC presenter Clive Myrie, also had Asif Sadiq MBE, senior vice president at WarnerMedia for Equity and Inclusion, International, and Sathya Bala, founder & CEO of True Change and My Skin My Story, a growing global community for women of color.

Ahmad said encouraging open conversations is important as there is great discomfort and stigma attached to talking about it, and many times senior leaders fall short in their efforts not because they have racist views or they don't believe in advancing race and ethnicity, but because they are not aware.

“I don't believe there is a silver bullet that an organization has found that can be sort of replicated elsewhere.

“Everybody is on their own journey. Every organization needs to approach it in a way that is best for its people, its consumer, clients, customers and the communities that it operates in.”

The focus on race and ethnicity needs to continue as “we may have created the change in the last sort of 18 months but we have not yet sustained it to make the impact that we want to see.”

Taking further from allowing open conversation, Bala said that data and stories are two key ingredients that can provide a gateway to reach to the core of the issue.

She said that stories about how racism impacts an individual’s life generate responses from people, they say “Oh, I relate to that. Or it was a little bit different for me”.

People are able to relate to such stories, generating empathy towards the subject, she said.

Emphasizing more on data and stories, she said the idea is to build “a bridge between people while also uncovering the realities of what those barriers and inequities are.”

Highlighting other challenges around race and ethnicity, Sadiq said “stereotypes is one of the big challenges, which we must address and create more education”.

He added that “micro aggressions seem to be quite prevalent, and even when they're done in a positive way, they exist a lot. And we need to challenge that because one of the things we end up having in any global organization is a dominant culture.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less